loader
Please Wait
Applying Filters...
menu
    • menu

    Annual Sales of Sacubitril-Valsartan reported using PharmaCompass' compilation of Annual Reports of Global Pharmaceutical Companies.

    Client Email Product
    PharmaCompass Sponsored Ads

    Virtual Booth

    Contact Supplier

    Bora Pharmaceuticals- Making success more certain.

    Virtual Booth

    Contact Supplier

    Polfa Tarchomin is a leading Polish pharmaceutical company with 200 year tradition in manufacture and sale of pharmaceutical products.

    Virtual Booth

    Contact Supplier

    PharmaCompass Sponsored Ads

    Virtual Booth

    Contact Supplier

    Axplora- The partner of choice for complex APIs.

    Virtual Booth

    Contact Supplier

    Fareva is a one-stop-shop for API/HPAPI, OSD & Sterile products, is USFDA, EMA and PMDA-inspected and has multiple NDA & ANDA filings.

    Virtual Booth

    Contact Supplier

    Menu

    Sacubitril-Valsartan

    ACTIVE PHARMA INGREDIENTS

    PRICE INFORMATION

    INTERMEDIATES

    FINISHED DOSAGE FORMULATIONS

    DIGITAL CONTENT

    GLOBAL SALES INFORMATION

    MARKET PLACE

    PharmaCompass
    $ API Ref.Price (USD/KG) : 2,327Xls

    Filters

    clear-filterReset all filters
    Filters Filter
    Cross PopUp
    FILTER :

    filter clear-filterReset all filters

    01 3Entresto

    PharmaCompass
    Left Arrow
    Right Arrow
    ListList of Suppliers
    refreshReset Filter
    refresh Reset Filter
    Price Info Price Info
    product-page Product Main Page

    01

    Brand Name : Entresto

    Sacubitril/Valsartan

    arrow
    Luxepack
    Not Confirmed

    Brand Name : Entresto

    Switzerland
    arrow
    Luxepack
    Not Confirmed

    Novartis

    Sacubitril/Valsartan

    Main Therapeutic Indication : Cardiovascular Diseases

    Currency : USD

    2021 Revenue in Millions : 3,548

    2020 Revenue in Millions : 2,497

    Growth (%) : 42

    blank

    Portfolio PDF

    Product Web Link

    Virtual Booth

    Digital Content

    Website

    Corporate PDF

    02

    Brand Name : Entresto

    Sacubitril/Valsartan

    arrow
    Luxepack
    Not Confirmed

    Brand Name : Entresto

    Switzerland
    arrow
    Luxepack
    Not Confirmed

    Novartis

    Sacubitril/Valsartan

    Main Therapeutic Indication : Cardiology/Vascular Diseases

    Currency : USD

    2022 Revenue in Millions : 4,644

    2021 Revenue in Millions : 3,548

    Growth (%) : 31

    blank

    Portfolio PDF

    Product Web Link

    Virtual Booth

    Digital Content

    Website

    Corporate PDF

    03

    Brand Name : Entresto

    Sacubitril/Valsartan

    arrow
    Luxepack
    Not Confirmed

    Brand Name : Entresto

    Switzerland
    arrow
    Luxepack
    Not Confirmed

    Novartis

    Sacubitril/Valsartan

    Main Therapeutic Indication : Cardiology/Vascular Diseases

    Currency : USD

    2023 Revenue in Millions : 6,035

    2022 Revenue in Millions : 4,644

    Growth (%) : 30

    blank

    Portfolio PDF

    Product Web Link

    Virtual Booth

    Digital Content

    Website

    Corporate PDF